Vito
Lv1
30 积分
2024-07-20 加入
-
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial
1个月前
已完结
-
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
2个月前
已完结
-
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
3个月前
已完结
-
Incidence and Prevalence of Diagnosed Vitiligo According to Race and Ethnicity, Age, and Sex in the US
3个月前
已完结
-
Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study
3个月前
已完结
-
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension
4个月前
已完结
-
Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study
5个月前
已完结
-
Impact of Site-Specific Metastases on Surgical Value and Survival among Metastatic Colorectal Cancer Patients
6个月前
已关闭
-
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer
6个月前
已完结
-
Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study
6个月前
已完结